Quotient Sciences Header

Quotient Sciences Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Medivir

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Medivir and Shijiazhuang Yuanmai Biotechnology Sign Licensing Agreement Regarding Manufacturing and Sales of Xerclear® in China

Details:

The agreement gives SYB the right to register, manufacture and market the product in China.

Lead Product(s): Aciclovir,Hydrocortisone

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Shijiazhuang Yuanmai Biotechnology

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement February 24, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY